Document Classification

Section Type: RESULTS

Text: Perindopril reduced arterial stiffness as indicated by increased systemic arterial compliance (mean [SEM], 0. 33 [0. 01] mL/mm Hg at baseline to 0. 54 [0. 04] mL/mm Hg at 24 weeks in perindopril group vs 0. 30 [0. 01] mL/mm Hg to 0. 29 [0. 01] mL/mm Hg in placebo group, P =. 004), and reduced central (7. 6 [0. 4] m/s to 5. 9 [0. 3] m/s in perindopril group, P <. 001 vs placebo) and peripheral (10. 9 [0. 4] m/s to 8. 7 [0. 4] m/s in perindopril group, P <. 001 vs placebo) pulse wave velocities.